Catalyst Wire Dossier Catalyst Wire Dossier

OLX10010

· Olix Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OLX10010, covering 2024-02-21 to 2024-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery [Phase 2]

See pricing